Post-operative Complications in Sickle Cell Disease Patients Abdulrahman Saleh Al-Mulhim et al Review article POST-OPERATIVE COMPLICATIONS IN SICKLE CELL DISEASE PATIENTS
Abdulrahman Saleh Al-Mulhim, Hessah Abdulaziz Al-Hussaini, Sara Abdullah Alnajjar, Marwah Abdulaziz Al- Awas, Alia Ali Alokley, Ilham Abdulrahman Almousa Medical College - King Faisal University, Kingdom of Saudi Arabia 1. INTRODUCTION Prevalence of post-operative complications in Sickle cell disease patients: Prevalence of sickle cell disease:
The post-operative complications can be broadly
Worldwide, sickle cell disease is seen in
classified into sickle-cell-related complications and
approximately 5% of population [1], and it is most
non-sickle-cell related complications. The most
common in people originally from sub-Saharan Africa,
common sickle-cell-related complication is vaso-
India, Saudi Arabia and Mediterranean countries [2]. In
occlusive crisis and the most serious is acute chest
Saudi Arabia, it is highly prevalent in the Eastern
syndrome. There are several factors that increase
region. The Saudi Premarital Screening Program
the risk of certain complications, like hemoglobin
estimated the prevalence of the sickle cell gene in the
S level, pre-operative blood transfusion, type of
adult population at 17% for sickle-cell trait and 1.2%
anesthesia, emergency-versus-elective surgeries,
type of surgery and laparoscopic-versus-open
Types of operations common in Sickle cell disease
surgeries [4],[6],[7],[8],[9],[10],[11],[12].
patients: 2. MAIN TYPES OF POST-OPERATIVE
All sickle cell disease patients can experience any type
COMPLICATIONS:
of surgery as the general population [4]. However, there
are certain operations that occur more frequently in
Sickle-cell-related Non-Sickle-cell- complications [4]
sickle cell disease patients in comparison to general
complications [4]
cholecystectomy, splenectomy and hip replacement [5].
Int j clin surg adv 2013; 1(2):41-50Post-operative Complications in Sickle Cell Disease Patients Abdulrahman Saleh Al-Mulhim et al 3. DEATH:
unpredictable recurrences of acute crises on
chronic pain creates a unique pain syndrome [15].
Most of postoperative mortality is mainly due the 4.2. Pathophysiology:
associated comorbid conditions, and second due to
In VOC, obstruction of blood flow results in
sickle-cell related complications. Bleeding, sepsis and
regional hypoxemia and acidosis. The severe pain
multi-organ failure are the most common sickle-cell
is believed to be caused by increased intra-
related causes of death postoperatively [4],[13].
medullary pressure, especially within the juxta-
Risk factors:
articular areas of long bones, secondary to an acute
The surgical procedure doesn't play a major role in
inflammatory response to vascular necrosis of the
causing postoperative death. However, high level of
bone marrow by sickled erythrocytes [15].
hemoglobin S, preoperative blood transfusion and
Risk factors:
high-risk surgeries (i.e. involving intracranial,
There are at least three sets of known predisposing
cardiovascular and thoracic procedures) increase the
events that seem to predict the frequency and
risk of postoperative death among sickle cell disease
severity of the acute sickle cell painful crisis:
genetic, cellular, and environmental/epigenetic
4. VASO-OCCLUSIVE CRISIS:
factors. Major reported factors that seem to
Definition:
precipitate acute painful crises include:
Vaso-occlusive crisis (VOC), also known as adult
Not related to Related to surgery [16],[17] surgery [14]
pain syndrome [14], is one of the common reason
Dehydration, stress of 1. General anesthesia any kind (physical, 2. Open surgery (e.g. traumatic,
hospitalizations in patients with sickle cell disease.
Sickle cell pain is often classified as either acute or
chronic. The acute type is caused by ischemic
acidosis, sleep apnea, climate, and pregnancy
tissue injury resulting from the occlusion of
microvascular beds by sickled erythrocytes during
an acute crisis. Chronic pain occurs because of the 4.3. Management:
destruction of bones, joints and visceral organs as a
Postoperative pain management is helped by
result of recurrent crises. The effect of
giving multiple analgesia. VOC treatment mainly
Int j clin surg adv 2013; 1(2):41-50Post-operative Complications in Sickle Cell Disease Patients Abdulrahman Saleh Al-Mulhim et al
consists of intravenous morphine, which has many
the pulmonary vasculature, a variety of inciting
dose-related side effects. Non-steroidal anti-
events triggers deoxygenation of hemoglobin S
inflammatory drugs have been proposed to provide
(Hgb S) leading to Hgb S polymerization and
pain relief and decrease the need for opioids [18].
sickling of the red blood cell that results in
4.4. Prevention:
vasoocclusion, ischemia, and endothelial injury [28].
Sickling is avoided by preventing risk factors
Multiple factors may be present and contribute to
mentioned above. Hydroxyurea can decrease the
ACS. They include inflammation (secondary to
infection or fat embolus), regional alveolar hypoxia
5. Acute chest syndrome: 5.1. Definition: Risk factors:
The acute chest syndrome (ACS) is the most
The following factors increase the risk of
common form of acute pulmonary disease in patients
with Sickle cell disease, occurring in almost one-half
of patients [19],[20]. It is the most frequently reported
cause of death in adults, and it is a risk factor for
early mortality [21],[22],[23]. ACS may present as a
Open surgery (ACS mostly occur within first 24
postoperative complication in children with Sickle
cell disease [24],[25]. A working definition of ACS in a
Management:
patient with sickle cell disease is the presence of a
The supportive management of an episode of ACS
new pulmonary infiltrate (not due to atelectasis,
requires a number of active interventions,
involving at least one complete lung segment),
including adequate pain control and fluid
respiratory symptoms (chest pain, dyspnea,
management [27], use of bronchodilators when
wheezing, or cough) and temperature >38.5ᵒC
wheezing is present, incentive spirometry to
prevent the development of pulmonary atelectasis,
5.2. Pathophysiology:
and use of supplemental oxygen [30]. Specific
The pathogenesis of acute pulmonary disease in
therapies for ACS include blood transfusion,
SCD is complex, and the establishment of a
specific cause in any single case is difficult. Within
Int j clin surg adv 2013; 1(2):41-50Post-operative Complications in Sickle Cell Disease Patients Abdulrahman Saleh Al-Mulhim et al
antibiotics and venous thromboembolism 7. Overwhelming postsplenectomy infection: Definition: Prevention:
Overwhelming postsplenectomy infection (OPSI)
is life-threatening complication of splenectomy. In
Careful perioperative management, including
general, it results in 3.2% for invasive infection
appropriate presurgical transfusion support and
and an overall mortality of 1.4% among adult
postoperative pulmonary care can minimize the
patients and in 1.7% of children. More than half of
these infections occur within the first two years
after splenectomy [36]. OPSI presents with mild
Hydroxyurea can prevent the recurrence of ACS
symptoms of flu-like such as low grade fever,
chills, muscle aches, and nausea followed by
subsequent rapid deterioration may occur in the
6. Stroke:
Stroke is an important and common complication
form of fatigue, colored skin, body weight loss,
of Sickle cell disease, affecting children as well as
abdominal pain, diarrhea, constipation, nausea, and
adults. Clinically evident stroke, usually brain
infarction, associated with stenosis or occlusion of
meningitis which can lead to fulminant sepsis,
the intracranial arteries of the Circle of Willis,
disseminated intravascular coagulation, and multi-
Japanese word for "hazy" or "like a puff of smoke"
Etiology:
that describes the appearance of an abnormal
Encapsulated bacteria are the primary causative
microvasculature on angiography believed
secondary to internal carotid artery stenosis or
Streptococcus pneumonia (causes 70% of
bacteremic episodes following splenectomy)
collateralization) [34]. Sickle cell disease confers a
greatly increased risk of ischemic and primary
Neisseria meningitides (meningococcus)
Int j clin surg adv 2013; 1(2):41-50Post-operative Complications in Sickle Cell Disease Patients Abdulrahman Saleh Al-Mulhim et al Management and prevention:
Appropriate and timely immunization [36]:
Anti-pneumococcal, anti-meningococcal and anti-
haemophilus influenza vaccines should be received
Pathophysiology:
Cefazoline or clindamycin should be administered,
homoeostasis will be disturbed, leading to
decreased clearance of particulate antigens from
the circulation, diminished clearance of opsonized
Penicillin V can be used postoperatively for 2
bacterial antigens, diminished primary humoral
years in adults and 5 years in children. Duration of
response to neoantigens, and diminished antibody
penicillin V can be extended according to patient
response to polysaccharides. Furthermore, IgM
memory B cells, which are responsible for
protecting against infection from encapsulated
Patients should understand the potential severity of
bacteria, require the spleen for their survival [37].
OPSI and the possibility of rapid progression.
Risk factors:
The time interval after splenectomy (most cases
In case of infection symptoms and fever higher
occur within 2 years postsplenectomy) [37]
than 38°C, early antibiotic therapy with amoxicillin
Sickle cell disease itself carries the highest risk for
clavulanate should be administered (or cefuroxime
Some surgeries can reduce the risk of OPSI, such
8. Fever and infection: Definition:
splenectomy during exploratory laparotomy for
Fever above 38ºC (100.4ºF) is common in the first
few days after major surgery. Most early
postoperative fever is caused by the inflammatory
stimulus of surgery and resolves spontaneously.
Int j clin surg adv 2013; 1(2):41-50Post-operative Complications in Sickle Cell Disease Patients Abdulrahman Saleh Al-Mulhim et al
However, postoperative fever can be a 8.4. Risk factors:
manifestation of a serious complication [40].
Pathophysiology:
Prolonged hospital stay (>24 hr) that may
Patients with Sickle cell disease are more
influenced by Sickle cell disease can increase the
susceptible to infections because of functional
risk of fever (0.5%) and respiratory complication
asplenia. Autoinfarction caused by sickling of red
blood cells results in a nonfunctioning spleen,
which is unable to filter bacteria from the blood
Simple transfusion is not associated with high
stream, and increase the risk of invasive infection
incidence of infection in comparison to aggressive
by encapsulated organism accordingly. Other than
having an infectious cause, fever is also a
manifestation of cytokine release in response to a
It decreases the risk of splenic sequestration in
variety of stimuli. Fever-associated cytokines,
Sickle cell and reduces the need for blood
including interleukin (IL)-1, IL-6, tumor necrosis
transfusions. So, infection rates did not increase
factor (TNF)-alpha, and interferon (IFN)-gamma,
after the procedure during the follow-up period
are produced by a variety of tissues and cells.
There is some evidence that IL-6 is the cytokine 8.5. Management and prevention:
most closely correlated with postoperative fever
All measures of immunization, antibiotic
prophylaxis and prompt treatment of infection are
Differential diagnosis [40]: Immediate Acute Subacute Delayed unnecessary treatments, including medications,
nasogastric tubes and intravascular and urinary
catheters should be discontinued in the febrile
Causes . Medications
patient. Treating the fever with acetaminophen is
9. Bleeding, thrombosis and embolism:
These postoperative complications are not common
in patients with sickle cell disease in comparison to
Int j clin surg adv 2013; 1(2):41-50Post-operative Complications in Sickle Cell Disease Patients Abdulrahman Saleh Al-Mulhim et al
the above mentioned complications. Some studies
Anesthesia in Sickle Cell Disease. Blood
mentioned that preoperative blood transfusion
increases the risk of these complications [4]. In
5. Adam S, Jonassaint J, Kruger H, Kail M, Orringer
addition, the risk of excessive blood loss varies
EP, Eckman JR et al. Surgical and Obstetric
according to the procedure [43]. A case report
Outcomes in Adults with Sickle Cell Disease. Am
mentioned that prolonged laparoscopic surgeries
can increase the risk of portal vein thrombosis [44].
6. Hirst C, Williamson L. Preoperative Blood
10. Conclusion:
Transfusions for Sickle Cell Disease. Cochrane
Database Syst Rev 2012 Jan 18;1:CD003149.
It has been approved that sickle cell diseases patients
7. Aziz AM, Meshikhes AW. Blood Transfusion in
are more susceptible to serious post-operative
complications compared to the general population.
These complications can be minimized by prompt
perioperative assessment and intervention.
Assessment of Perioperative Transfusion Therapy
REFERENCES
and Complications in Sickle Cell Disease Patients
1. Sickle-cell Disease and Other Haemoglobin
Disorders [Online]. 2011 Jan; Available from:
URL:http://www.who.int/mediacentre/factsheets/f
Cholecystectomy in Adult Patients with Sickle
Cell Disease. Surg Laparosc Endosc Percutan
2. Sickle-cell Anaemia [Online]. 2006 April 24;
Available from: URL:http://apps.who.int/gb
10. Al-Mulhim AS, Al-Mulhim AA. Laparoscopic
Cholecystectomy in 427 Adults with Sickle Cell
3. Jastaniah W. Epidemiology of Sickle Cell Disease
Disease: A Single-center Experience. Surg
in Saudi Arabia. Ann Saudi Med. 2011 May-
4. Koshy M, Weiner SJ, Miller ST, Sleeper LA,
Vichinsky E, Brown AK et al. Surgery and
Int j clin surg adv 2013; 1(2):41-50Post-operative Complications in Sickle Cell Disease Patients Abdulrahman Saleh Al-Mulhim et al
11. Al-Mulhim AS. Laparoscopic Splenectomy for
Massive Splenomegaly in Benign Hematological
Diseases. Surg Endosc 2012 Nov;26(11):3186-9.
Ketoprofen for Sickle-cell Disease Vaso-occlusive
Laparoscopic Splenectomy and/or Crises in Adults. Blood
Cholecystectomy for Children with Sickle Cell
Disease. Pediatr Surg Int 2009 May;25(5):417-21.
13. Manci EA, Culberson DE, Yang YM, Gardner
Complications of Sickle Cell Anemia. A Need for
TM, Powell R, Haynes J Jr et al. Causes of
Increased Recognition, Treatment, and Research.
Death in Sickle Cell Disease: An Autopsy Study.
Am J Respir Crit Care Med 2001; 164(11):2016-
GA, Dampier C, Osunkwo I et al. Beyond the
Complications of Sickle Cell Disease. Semin
Definitions of the Phenotypic Complications
21. Gray A, Anionwu EN, Davies SC, Brozovic M.
Patterns of mortality in sickle cell disease in the
ScientificWorldJournal 2012;2012:949535.
United Kingdom. J Clin Pathol 1991; 44:459.
15. Yale SH, Nagib N, Guthrie T. Approach to the
22. Platt OS, Brambilla DJ, Rosse WF, et al.
Vaso-occlusive Crisis in Adults with Sickle Cell
Mortality in sickle cell disease. Life expectancy
and risk factors for early death. N Engl J Med
Sani 23. Gladwin MT, Schechter AN, Shelhamer JH,
CM, Habibou A. Laparoscopic Cholecystectomy
Ognibene FP. The acute chest syndrome in sickle
in Sickle Cell Patients in Niger. Pan Afr Med
cell disease. Possible role of nitric oxide in its
pathophysiology and treatment. Am J Respir Crit
17. Al-Ebrahim KE. Cardiac Surgery and Sickle Cell
24. Platt OS. The acute chest syndrome of sickle cell
Int j clin surg adv 2013; 1(2):41-50Post-operative Complications in Sickle Cell Disease Patients Abdulrahman Saleh Al-Mulhim et al
25. Wales PW, Carver E, Crawford MW, Kim PC.
32. Ballas SK, Lieff S, Benjamin LJ, et al. Definitions
Acute chest syndrome after abdominal surgery in
of the phenotypic manifestations of sickle cell
children with sickle cell disease: Is a laparoscopic
approach better? J Pediatr Surg 2001; 36:718.
33. Charache S, Terrin ML, Moore RD, et al. Effect
of hydroxyurea on the frequency of painful crises
complications of sickle cell disease. N Engl J Med
in sickle cell anemia. Investigators of the
Multicenter Study of Hydroxyurea in Sickle Cell
27. Vichinsky EP, Neumayr LD, Earles AN, et al.
Causes and outcomes of the acute chest syndrome
34. Gebreyohanns M, Adams RJ. Sickle Cell Disease:
in sickle cell disease. National Acute Chest
Primary Stroke Prevention. CNS Spectr 2004
Syndrome Study Group. N Engl J Med 2000;
35. Strouse JJ, Jordan LC, Lanzkron S, Casella JF.
28. Boyd JH, DeBaun MR, Morgan WJ, et al. Lower
The Excess Burden of Stroke in Hospitalized
airway obstruction is associated with increased
Adults with Sickle Cell Disease. Am J Hematol
morbidity in children with sickle cell disease.
36. Romano F, Garancini M, Ciravegna AL, Uggeri
29. Graham LM. Sickle cell disease: pulmonary
F, Degrate L, Maternini M. The Implications for
management options. Pediatr Pulmonol Suppl
Patients Undergoing Splenectomy: Postsurgery
Risk Management. Dove Press Journal: Open
30. Powars D, Weidman JA, Odom-Maryon T, et al.
Access Surgery 2011 Aug; 2011(4): 21-34.
Sickle cell chronic lung disease: prior morbidity
37. Lammers AJ. The Value of Prophylactic
and the risk of pulmonary failure. Medicine
Vaccinations and Antibiotic Treatment in Post-
splenectomy Patients: A Review. Dove Press
31. Godeau B, Schaeffer A, Bachir D, et al.
Bronchoalveolar lavage in adult sickle cell
patients with acute chest syndrome: value for
38. Pasternack MS. Prevention of Sepsis in the
diagnostic assessment of fat embolism. Am J
Int j clin surg adv 2013; 1(2):41-50Post-operative Complications in Sickle Cell Disease Patients Abdulrahman Saleh Al-Mulhim et al
URL:http://www.uptodate.com/contents/preventio
Postsplenectomy Infection Syndrome in Adults -
A Clinically Preventable Disease. World J
CORRESPONDENCE:
Gastroenterol 2008 January 14; 14(2): 176–179.
Dr. Abdulrahman Saleh Al-Mulhim, Associate Professor of Surgery
40. Weed HG, Baddour LM. Postoperative Fever
Department of Surgery Medical College - King Faisal University,
[Online]. 2012 March 21. Available from:
Hofuf, P.O. Box 1164Al-Hassa 31982 Kingdom of Saudi Arabia E-mail address: [email protected]
URL:http://www.uptodate.com/contents/postopera
tivefever?source=search_result&search=postopera
tive+fever+in+sickle+cell+disease&selectedTitle=
41. Wali YA, al Okbi H, al Abri R. A Comparison of
Two Transfusion Regimens in the Perioperative
Disease Undergoing Adenotonsillectomy. Pediatr
Splenectomy Prevents Splenic Sequestration
Crises in Sickle Cell Disease. J Pediatr Surg 2009
43. Sathappan SS, Ginat D, Di Cesare PE.
Management of Orthopedic Patients with Sickle C
ell Disease. Orthopedics 2006 Dec;29(12):1094-
Following Laparoscopic Surgery in a Patient with
Int j clin surg adv 2013; 1(2):41-50
“I was about 50 meters away when it blew up. The blast knocked me off my feet and into the side of a Humvee. I must have blacked out for a minute or two, but when I came to there was nothing left of the vehicle. No remnants; just char and a crater.” When 28-year-old Christopher Harmon was discharged on May 26,2006, after eight years in the Marine Corps, he had a chestful of dec-oration